Emotional wellbeing of blind patients in a pilot trial with subretinal implants
- First Online:
- 208 Downloads
Participation in first human applications of retinal neuroprosthesis may create psychological stress for blind retinitis pigmentosa patients. The aim of this study was to assess the emotional wellbeing of patients undergoing implantation of a subretinal implant.
Nine blind patients participating in a pilot trial with subretinal implants were enlisted. The Brief Symptom Inventory (BSI), a short self-report scale of nine primary symptoms, was used to assess reaction to the psychological distress related to study participation. The number and the intensity of symptoms were analysed, and global scores for overall psychological distress (tGSI), severity of reported symptoms (tPDSI), and level number of self-reported symptoms (tPST) were calculated. The questionnaire was administered before implantation, 2–3 times during the trial and before explantation.
There were no significant alterations during the trial for the average scores of the nine primary symptoms. One patient, however, showed values higher than the norm, for six subscores before implantation and for eight subscores before explantation. A significant improvement was found in both the overall psychological distress level (tGSI) and the severity of reported symptoms (tPDSI) at the final visit, compared to those at the study start. The number of self-reported symptoms (tPST) was not significantly altered.
In the first ongoing pilot trial with an active, cable-bound subretinal implant, we found that trial participation and the implant procedure and subsequent testing did not have any adverse effects on the participants’ emotional wellbeing. Their distress generally improved during study participation, rather than showing signs of decreased wellbeing.
KeywordsEmotional wellbeing Retina Implant
- 1.Zrenner E (2002) The subretinal implant: can microphotodiode arrays replace degenerated retinal photoreceptors to restore vision? Ophthalmol 216(Suppl 1):8–20, discussion 52–23Google Scholar
- 2.Gekeler F, Sachs H, Szurman P, Messias A, Wilke R, Besch D, Wilhelm B, Zrenner E, Bartz-Schmidt K, Gelisken F (2007) Fluorescein angiographic findings in blind patients treated by an active subretinal implant. Invest Ophthalmol Vis Sci 48:2567Google Scholar
- 3.Zrenner E, Wilke R, Zabel T, Sachs H, Bartz-Schmidt K, Gekeler F, Wilhelm B, Greppmaier U, Stett A, SUBRET Study Group (2007) Psychometric analysis of visual sensations mediated by subretinal microelectrode arrays implanted into blind retinitis pigmentosa patients. Invest Ophthalmol Vis Sci 48:659Google Scholar
- 4.Besch D, Sachs H, Szurman P, Gulicher D, Wilke R, Reinert S, Zrenner E, Bartz-Schmidt KU, Gekeler F (2008) Extraocular surgery for implantation of an active subretinal visual prosthesis with external connections: feasibility and outcome in seven patients. Br J Ophthalmol 92:1361–1368PubMedCrossRefGoogle Scholar
- 5.Zrenner E, Wilke R, Sachs H, Bartz-Schmidt K, Gekelar F, Besch D et al (2008) Visual sensation mediated by subretinal microelectrode arrays implanted into blind retinitis pigmentosa patients. Biomed Tech 53(Suppl 1):218–220Google Scholar
- 7.Zrenner E, Bartz-Schmidt KU, Benav H, Besch D, Bruckmann A, Gabel VP, Gekeler F, Greppmaier U, Harscher A, Kibbel S, Koch J, Kusnyerik A, Peters T, Stingl K, Sachs H, Stett A, Szurman P, Wilhelm B, Wilke R (2011) Subretinal electronic chips allow blind patients to read letters and combine them to words. Proc R Soc B 278:1489–1497PubMedCrossRefGoogle Scholar